The Savings that Cost More: New Report Puts a Number on Europe's Innovation Choice

The savings that cost more: new report puts a number on Europe’s innovation choice

This release is intended for the general public, healthcare professionals, policymakers and other healthcare decision-makers, plus pharmaceutical, policy and trade media.

The savings that cost more: new report puts a number on Europe's innovation choice

This release is intended for the general public, healthcare professionals, policymakers and other healthcare decision-makers, plus pharmaceutical, policy and trade media.

EY Report Examines How Europe’s Pharmaceutical Innovation Policies Could Shape Healthcare Costs and Competitiveness by 2035

Boehringer-commissioned analysis compares eight countries and EU-level policies, illustrating the potential economic, healthcare and strategic implications of different innovation pathways. IN BRIEFKEY TAKEAWAYSFAQs EY’s Innovation at a Crossroads report, commissioned by Boehringer Ingelheim, examines how alternative pharmaceutical innovation policies could … Read the full press release →